Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo

Chitra Mandal, Sayantani Sarkar, Devawati Dutta, Suman Kumar Samanta, Kaushik Bhattacharya, Bikas Chandra Pal, Jinping Li, Kaustubh Datta, Chhabinath Mandal

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Pancreatic cancer is almost always fatal, in part because of its delayed diagnosis, poor prognosis, rapid progression and chemoresistance. Oncogenic proteins are stabilized by the Hsp90, making it a potential therapeutic target. We investigated the oxidative stress-mediated dysfunction of Hsp90 and the hindrance of its chaperonic activity by a carbazole alkaloid, mahanine, as a strategic therapeutic in pancreatic cancer. Mahanine exhibited antiproliferative activity against several pancreatic cancer cell lines through apoptosis. It induced early accumulation of reactive oxygen species (ROS) leading to thiol oxidation, aggregation and dysfunction of Hsp90 in MIAPaCa-2. N-acetyl-L-cysteine prevented mahanine-induced ROS accumulation, aggregation of Hsp90, degradation of client proteins and cell death. Mahanine disrupted Hsp90-Cdc37 complex in MIAPaCa-2 as a consequence of ROS generation. Client proteins were restored by MG132, suggesting a possible role of ubiquitinylated protein degradation pathway. Surface plasmon resonance study demonstrated that the rate of interaction of mahanine with recombinant Hsp90 is in the range of seconds. Molecular dynamics simulation showed its weak interactions with Hsp90. However, no disruption of the Hsp90-Cdc37 complex was observed at an early time point, thus ruling out that mahanine directly disrupts the complex. It did not impede the ATP binding pocket of Hsp90. Mahanine also reduced in vitro migration and tube formation in cancer cells. Further, it inhibited orthotopic pancreatic tumor growth in nude mice. Taken together, these results provide evidence for mahanine-induced ROS-mediated destabilization of Hsp90 chaperone activity resulting in Hsp90-Cdc37 disruption leading to apoptosis, suggesting its potential as a specific target in pancreatic cancer. What's new? Pancreatic cancer is lethal and often shows resistance to conventional chemotherapy. New drugs and/or combinations of drugs are required for greater efficacy as well as to overcome the observed chemoresistance. Hsp90 is highly expressed in cancerous cells for their survival, making it a potential chemotherapy target. ROS is a critical mediator of apoptosis and can lead to Hsp90 dysfunction. Our data demonstrate the involvement of mahanine-induced ROS in Hsp90 dysfunction which leads to a subsequent disruption of the Hsp90-Cdc37 chaperone complex in pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)695-706
Number of pages12
JournalInternational Journal of Cancer
Volume132
Issue number3
DOIs
StatePublished - Feb 1 2013

Fingerprint

Adenocarcinoma
Pancreatic Neoplasms
Reactive Oxygen Species
Apoptosis
Proteolysis
In Vitro Techniques
mahanine
Drug Therapy
Surface Plasmon Resonance
Delayed Diagnosis
Acetylcysteine
Drug Combinations
Molecular Dynamics Simulation
Alkaloids
Sulfhydryl Compounds
Nude Mice
Neoplasms
Cell Survival
Proteins
Oxidative Stress

Keywords

  • Cdc37
  • Hsp90
  • apoptosis
  • mahanine
  • pancreatic cancer
  • reactive oxygen species

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo. / Mandal, Chitra; Sarkar, Sayantani; Dutta, Devawati; Samanta, Suman Kumar; Bhattacharya, Kaushik; Pal, Bikas Chandra; Li, Jinping; Datta, Kaustubh; Mandal, Chhabinath.

In: International Journal of Cancer, Vol. 132, No. 3, 01.02.2013, p. 695-706.

Research output: Contribution to journalArticle

Mandal, Chitra ; Sarkar, Sayantani ; Dutta, Devawati ; Samanta, Suman Kumar ; Bhattacharya, Kaushik ; Pal, Bikas Chandra ; Li, Jinping ; Datta, Kaustubh ; Mandal, Chhabinath. / Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo. In: International Journal of Cancer. 2013 ; Vol. 132, No. 3. pp. 695-706.
@article{967f07b04aa3452ba2ae867f524e1f4d,
title = "Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo",
abstract = "Pancreatic cancer is almost always fatal, in part because of its delayed diagnosis, poor prognosis, rapid progression and chemoresistance. Oncogenic proteins are stabilized by the Hsp90, making it a potential therapeutic target. We investigated the oxidative stress-mediated dysfunction of Hsp90 and the hindrance of its chaperonic activity by a carbazole alkaloid, mahanine, as a strategic therapeutic in pancreatic cancer. Mahanine exhibited antiproliferative activity against several pancreatic cancer cell lines through apoptosis. It induced early accumulation of reactive oxygen species (ROS) leading to thiol oxidation, aggregation and dysfunction of Hsp90 in MIAPaCa-2. N-acetyl-L-cysteine prevented mahanine-induced ROS accumulation, aggregation of Hsp90, degradation of client proteins and cell death. Mahanine disrupted Hsp90-Cdc37 complex in MIAPaCa-2 as a consequence of ROS generation. Client proteins were restored by MG132, suggesting a possible role of ubiquitinylated protein degradation pathway. Surface plasmon resonance study demonstrated that the rate of interaction of mahanine with recombinant Hsp90 is in the range of seconds. Molecular dynamics simulation showed its weak interactions with Hsp90. However, no disruption of the Hsp90-Cdc37 complex was observed at an early time point, thus ruling out that mahanine directly disrupts the complex. It did not impede the ATP binding pocket of Hsp90. Mahanine also reduced in vitro migration and tube formation in cancer cells. Further, it inhibited orthotopic pancreatic tumor growth in nude mice. Taken together, these results provide evidence for mahanine-induced ROS-mediated destabilization of Hsp90 chaperone activity resulting in Hsp90-Cdc37 disruption leading to apoptosis, suggesting its potential as a specific target in pancreatic cancer. What's new? Pancreatic cancer is lethal and often shows resistance to conventional chemotherapy. New drugs and/or combinations of drugs are required for greater efficacy as well as to overcome the observed chemoresistance. Hsp90 is highly expressed in cancerous cells for their survival, making it a potential chemotherapy target. ROS is a critical mediator of apoptosis and can lead to Hsp90 dysfunction. Our data demonstrate the involvement of mahanine-induced ROS in Hsp90 dysfunction which leads to a subsequent disruption of the Hsp90-Cdc37 chaperone complex in pancreatic cancer.",
keywords = "Cdc37, Hsp90, apoptosis, mahanine, pancreatic cancer, reactive oxygen species",
author = "Chitra Mandal and Sayantani Sarkar and Devawati Dutta and Samanta, {Suman Kumar} and Kaushik Bhattacharya and Pal, {Bikas Chandra} and Jinping Li and Kaustubh Datta and Chhabinath Mandal",
year = "2013",
month = "2",
day = "1",
doi = "10.1002/ijc.27687",
language = "English (US)",
volume = "132",
pages = "695--706",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo

AU - Mandal, Chitra

AU - Sarkar, Sayantani

AU - Dutta, Devawati

AU - Samanta, Suman Kumar

AU - Bhattacharya, Kaushik

AU - Pal, Bikas Chandra

AU - Li, Jinping

AU - Datta, Kaustubh

AU - Mandal, Chhabinath

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Pancreatic cancer is almost always fatal, in part because of its delayed diagnosis, poor prognosis, rapid progression and chemoresistance. Oncogenic proteins are stabilized by the Hsp90, making it a potential therapeutic target. We investigated the oxidative stress-mediated dysfunction of Hsp90 and the hindrance of its chaperonic activity by a carbazole alkaloid, mahanine, as a strategic therapeutic in pancreatic cancer. Mahanine exhibited antiproliferative activity against several pancreatic cancer cell lines through apoptosis. It induced early accumulation of reactive oxygen species (ROS) leading to thiol oxidation, aggregation and dysfunction of Hsp90 in MIAPaCa-2. N-acetyl-L-cysteine prevented mahanine-induced ROS accumulation, aggregation of Hsp90, degradation of client proteins and cell death. Mahanine disrupted Hsp90-Cdc37 complex in MIAPaCa-2 as a consequence of ROS generation. Client proteins were restored by MG132, suggesting a possible role of ubiquitinylated protein degradation pathway. Surface plasmon resonance study demonstrated that the rate of interaction of mahanine with recombinant Hsp90 is in the range of seconds. Molecular dynamics simulation showed its weak interactions with Hsp90. However, no disruption of the Hsp90-Cdc37 complex was observed at an early time point, thus ruling out that mahanine directly disrupts the complex. It did not impede the ATP binding pocket of Hsp90. Mahanine also reduced in vitro migration and tube formation in cancer cells. Further, it inhibited orthotopic pancreatic tumor growth in nude mice. Taken together, these results provide evidence for mahanine-induced ROS-mediated destabilization of Hsp90 chaperone activity resulting in Hsp90-Cdc37 disruption leading to apoptosis, suggesting its potential as a specific target in pancreatic cancer. What's new? Pancreatic cancer is lethal and often shows resistance to conventional chemotherapy. New drugs and/or combinations of drugs are required for greater efficacy as well as to overcome the observed chemoresistance. Hsp90 is highly expressed in cancerous cells for their survival, making it a potential chemotherapy target. ROS is a critical mediator of apoptosis and can lead to Hsp90 dysfunction. Our data demonstrate the involvement of mahanine-induced ROS in Hsp90 dysfunction which leads to a subsequent disruption of the Hsp90-Cdc37 chaperone complex in pancreatic cancer.

AB - Pancreatic cancer is almost always fatal, in part because of its delayed diagnosis, poor prognosis, rapid progression and chemoresistance. Oncogenic proteins are stabilized by the Hsp90, making it a potential therapeutic target. We investigated the oxidative stress-mediated dysfunction of Hsp90 and the hindrance of its chaperonic activity by a carbazole alkaloid, mahanine, as a strategic therapeutic in pancreatic cancer. Mahanine exhibited antiproliferative activity against several pancreatic cancer cell lines through apoptosis. It induced early accumulation of reactive oxygen species (ROS) leading to thiol oxidation, aggregation and dysfunction of Hsp90 in MIAPaCa-2. N-acetyl-L-cysteine prevented mahanine-induced ROS accumulation, aggregation of Hsp90, degradation of client proteins and cell death. Mahanine disrupted Hsp90-Cdc37 complex in MIAPaCa-2 as a consequence of ROS generation. Client proteins were restored by MG132, suggesting a possible role of ubiquitinylated protein degradation pathway. Surface plasmon resonance study demonstrated that the rate of interaction of mahanine with recombinant Hsp90 is in the range of seconds. Molecular dynamics simulation showed its weak interactions with Hsp90. However, no disruption of the Hsp90-Cdc37 complex was observed at an early time point, thus ruling out that mahanine directly disrupts the complex. It did not impede the ATP binding pocket of Hsp90. Mahanine also reduced in vitro migration and tube formation in cancer cells. Further, it inhibited orthotopic pancreatic tumor growth in nude mice. Taken together, these results provide evidence for mahanine-induced ROS-mediated destabilization of Hsp90 chaperone activity resulting in Hsp90-Cdc37 disruption leading to apoptosis, suggesting its potential as a specific target in pancreatic cancer. What's new? Pancreatic cancer is lethal and often shows resistance to conventional chemotherapy. New drugs and/or combinations of drugs are required for greater efficacy as well as to overcome the observed chemoresistance. Hsp90 is highly expressed in cancerous cells for their survival, making it a potential chemotherapy target. ROS is a critical mediator of apoptosis and can lead to Hsp90 dysfunction. Our data demonstrate the involvement of mahanine-induced ROS in Hsp90 dysfunction which leads to a subsequent disruption of the Hsp90-Cdc37 chaperone complex in pancreatic cancer.

KW - Cdc37

KW - Hsp90

KW - apoptosis

KW - mahanine

KW - pancreatic cancer

KW - reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=84870245054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870245054&partnerID=8YFLogxK

U2 - 10.1002/ijc.27687

DO - 10.1002/ijc.27687

M3 - Article

C2 - 22729780

AN - SCOPUS:84870245054

VL - 132

SP - 695

EP - 706

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -